ASX: RGT

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

IBM’s planned acquisition of HRL Laboratories could strengthen its quantum computing roadmap by adding silicon-spin qubit technology and expanding its advanced semiconductor research capabilities. Representative image.

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

WSP Global raises Arcadis takeover offer to €51.50 as engineering consolidation accelerates

Wall Street welcomes Repligen’s $1.5bn BioLife deal, but integration now matters

Argent BioPharma (ASX: RGT) acquires AusCann assets in $15m deal — can it unlock U.S. listing potential?

Argent BioPharma acquires AusCann assets in a $15M deal to expand its clinical pipeline, strengthen EU infrastructure, and advance toward a U.S. listing.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

August 28, 2025